BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 523718)

  • 1. [Experiments on the treatment of Yoshida tumor with neuroaminidase of Vibrio cholerae].
    Sánchez Cousteau JA; Justo Alpañes E; Ledro Molina D; Ferreiro Madueño M; Gomez Parra M; Ramírez Martínez R; Valle Bernal MJ; Astolfi Pérez de Guzmán J; Garrido Peralta M
    Rev Clin Esp; 1979 Sep; 154(5):183-6. PubMed ID: 523718
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of growth of rat Yoshida sarcoma using a neuraminidase treated tumour vaccine.
    Ray PK; Seshadri M
    Indian J Exp Biol; 1979 Jan; 17(1):36-9. PubMed ID: 468316
    [No Abstract]   [Full Text] [Related]  

  • 3. Metastatic sarcoma. Combined surgical and immunotherapeutic approach. Neuraminidase treated tumor cells as tumor vaccine.
    Gunnarsson A; McKhann CF; Simmons RL; Grage TB
    Minn Med; 1974 Jul; 57(7):558-61. PubMed ID: 4845897
    [No Abstract]   [Full Text] [Related]  

  • 4. The immunotherapy of advanced human cancer with neuraminidase.
    Ngu VA; Osunkoya BO; Ajayi OO; Khwaja MS
    Niger Med J; 1973 Jan; 3(1):15-9. PubMed ID: 4805217
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.
    Simmons RL; Rios A
    Johns Hopkins Med J Suppl; 1974; 3():75-84. PubMed ID: 4536589
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.
    Simmons RL; Rios A
    Natl Cancer Inst Monogr; 1973 Dec; 39():57-68. PubMed ID: 4595327
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental and clinical trials with BCG immunotherapy.
    Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
    Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuraminidase treated cells and their role in cancer immunotherapy.
    Simmons RL; Rios A
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.
    Simmons RL; Rios A
    Transplant Proc; 1975 Jun; 7(2):247-51. PubMed ID: 1129845
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant immunotherapy of malignant melanoma.
    Aranha GV; McKhann CF; Grage TB; Gunnarsson A; Simmons RL
    Cancer; 1979 Apr; 43(4):1297-303. PubMed ID: 445331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuraminidase immunotherapy of tumors in man.
    Rosato FE; Brown AS; Miller EE; Rosato EF; Mullis WF; Johnson J; Moskovitz A
    Surg Gynecol Obstet; 1974 Nov; 139(5):675-82. PubMed ID: 4428323
    [No Abstract]   [Full Text] [Related]  

  • 12. Spontaneous mammary tumors in mongrel dogs. A relevant model to demonstrate tumor therapeutical success by application of neuraminidase-treated tumor cells.
    Sedlacek HH; Seiler FR
    Dev Biol Stand; 1977 Apr 13-15; 38():399-412. PubMed ID: 608530
    [No Abstract]   [Full Text] [Related]  

  • 13. Possible immunological action of Vibrio cholerae neuraminidase (VCN) in tumor immunotherapy.
    Sedlacek HH; Johannsen R; Seiler FR
    Dev Biol Stand; 1977 Apr 13-15; 38():387-98. PubMed ID: 608528
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy with neuraminidase-treated tumor cells after radiotherapy.
    Song CW; Levitt SH
    Radiat Res; 1975 Dec; 64(3):485-91. PubMed ID: 1197655
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiation therapy and immunotherapy: the value of immunotherapy in the control of local and regional cancer.
    Cancer; 1976 Apr; 37(4 Suppl):2108-19. PubMed ID: 769945
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of the enzyme neuraminidase for immunotherapeutic treatment of chemically induced carcinogenesis].
    Maĭskiĭ IN; Aĭrapet'ian GP; Kobrinskiĭ GD; Troitskaia NA; Gudkova GB
    Biull Eksp Biol Med; 1977 Dec; 84(12):714-7. PubMed ID: 413595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of endogenous FSH by neuraminidase from Vibrio cholerae.
    Finné E
    Endokrinologie; 1978 Nov; 72(3):365-6. PubMed ID: 744182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicological studies with therapeutically-applicable Vibrio cholerae neuraminidase.
    Ronneberger H
    Dev Biol Stand; 1977 Apr 13-15; 38():413-9. PubMed ID: 608531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional lymphatics and the mechanism of action of neuraminidase.
    Ziegler MM; Miller EE; Barker CF
    Surg Forum; 1973; 24():290-2. PubMed ID: 4806011
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-Guérin and neuraminidase.
    Sparks FC; Breeding JH
    Cancer Res; 1974 Dec; 34(12):3262-9. PubMed ID: 4471640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.